638 related articles for article (PubMed ID: 20510759)
1. Innovative management of lupus erythematosus.
Knott HM; Martínez JD
Dermatol Clin; 2010 Jul; 28(3):489-99. PubMed ID: 20510759
[TBL] [Abstract][Full Text] [Related]
2. Pimecrolimus 1% cream for cutaneous lupus erythematosus.
Kreuter A; Gambichler T; Breuckmann F; Pawlak FM; Stücker M; Bader A; Altmeyer P; Freitag M
J Am Acad Dermatol; 2004 Sep; 51(3):407-10. PubMed ID: 15337984
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
Walling HW; Sontheimer RD
Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
[TBL] [Abstract][Full Text] [Related]
4. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
[TBL] [Abstract][Full Text] [Related]
5. The different faces of cutaneous lupus erythematosus.
Renner R; Sticherling M
G Ital Dermatol Venereol; 2009 Apr; 144(2):135-47. PubMed ID: 19357621
[TBL] [Abstract][Full Text] [Related]
6. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.
Jewell ML; McCauliffe DP
J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400
[TBL] [Abstract][Full Text] [Related]
7. Management of "refractory" skin disease in patients with lupus erythematosus.
Callen JP
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):767-84. PubMed ID: 16150402
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cutaneous lesions in patients with lupus erythematosus.
Callen JP
Dermatol Clin; 1994 Jan; 12(1):201-6. PubMed ID: 8143382
[TBL] [Abstract][Full Text] [Related]
9. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of generalized discoid skin lesions with azathioprine. Its use in a patient with systemic lupus erythematosus.
Tsokos GC; Caughman SW; Klippel JH
Arch Dermatol; 1985 Oct; 121(10):1323-5. PubMed ID: 4037829
[TBL] [Abstract][Full Text] [Related]
11. Pulse cyclophosphamide treatment for severe refractory cutaneous lupus erythematosus.
Raptopoulou A; Linardakis C; Sidiropoulos P; Kritikos HD; Boumpas DT
Lupus; 2010 May; 19(6):744-7. PubMed ID: 20179172
[TBL] [Abstract][Full Text] [Related]
12. Management of skin disease in lupus.
Callen JP
Bull Rheum Dis; 1997 Apr; 46(2):4-7. PubMed ID: 9104044
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive drug therapy of systemic lupus erythematosus.
Fox DA; McCune WJ
Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402
[TBL] [Abstract][Full Text] [Related]
14. [Lupus erythematosus; current treatment methods].
Baart de la Faille H
Ned Tijdschr Geneeskd; 1992 Oct; 136(42):2052-6. PubMed ID: 1407206
[No Abstract] [Full Text] [Related]
15. Epidemiological characteristics of patients with cutaneous lupus erythematosus.
Avilés Izquierdo JA; Cano Martínez N; Lázaro Ochaita P
Actas Dermosifiliogr; 2014; 105(1):69-73. PubMed ID: 24268922
[TBL] [Abstract][Full Text] [Related]
16. Management of cutaneous lupus erythematosus.
Tuffanelli DL
Clin Dermatol; 1985; 3(3):123-30. PubMed ID: 3880020
[No Abstract] [Full Text] [Related]
17. [Thalidomide and thrombosis].
Flageul B; Wallach D; Cavelier-Balloy B; Bachelez H; Carsuzaa F; Dubertret L
Ann Dermatol Venereol; 2000 Feb; 127(2):171-4. PubMed ID: 10739975
[TBL] [Abstract][Full Text] [Related]
18. [Antimalarials in lupus erythematosus treatment].
Woźniacka A
Przegl Lek; 2002; 59(3):179-82. PubMed ID: 12184034
[TBL] [Abstract][Full Text] [Related]
19. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
Jedlickova H; Bohmová J; Sirotkova A
Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028
[No Abstract] [Full Text] [Related]
20. The use of topical calcineurin inhibitors in lupus erythematosus: an overview.
Wollina U; Hansel G
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):1-6. PubMed ID: 18005117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
